Paula W. Allan

1.9k total citations
69 papers, 1.5k citations indexed

About

Paula W. Allan is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Paula W. Allan has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 27 papers in Epidemiology and 18 papers in Infectious Diseases. Recurrent topics in Paula W. Allan's work include Biochemical and Molecular Research (36 papers), Cytomegalovirus and herpesvirus research (20 papers) and Adenosine and Purinergic Signaling (17 papers). Paula W. Allan is often cited by papers focused on Biochemical and Molecular Research (36 papers), Cytomegalovirus and herpesvirus research (20 papers) and Adenosine and Purinergic Signaling (17 papers). Paula W. Allan collaborates with scholars based in United States, Egypt and Taiwan. Paula W. Allan's co-authors include L. Lee Bennett, William B. Parker, Eric J. Sorscher, William R. Waud, John A. Secrist, John A. Montgomery, Donald L. Hill, Lucy M. Rose, G. Yancey Gillespie and Sue C. Shaddix and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

In The Last Decade

Paula W. Allan

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula W. Allan United States 23 1.1k 431 399 306 280 69 1.5k
Fernanda Canduri Brazil 28 1.2k 1.1× 106 0.2× 234 0.6× 253 0.8× 274 1.0× 66 1.6k
Federico Focher Italy 27 1.0k 1.0× 182 0.4× 407 1.0× 406 1.3× 267 1.0× 95 1.7k
Gopalan Soman United States 19 414 0.4× 131 0.3× 176 0.4× 166 0.5× 241 0.9× 39 1.3k
Priscilla P. Saunders United States 17 768 0.7× 150 0.3× 154 0.4× 218 0.7× 110 0.4× 38 1.1k
I K Dev United States 24 975 0.9× 248 0.6× 156 0.4× 198 0.6× 415 1.5× 35 1.6k
Charles Garrett United States 9 1.2k 1.1× 146 0.3× 175 0.4× 181 0.6× 209 0.7× 10 1.5k
David H. Ives United States 18 991 0.9× 77 0.2× 178 0.4× 215 0.7× 153 0.5× 37 1.3k
Shizuko Sei United States 26 512 0.5× 271 0.6× 306 0.8× 629 2.1× 478 1.7× 73 1.9k
D. B. Thomas Tanzania 24 881 0.8× 136 0.3× 362 0.9× 123 0.4× 153 0.5× 69 1.9k
Gerald Bacher Switzerland 16 637 0.6× 163 0.4× 278 0.7× 319 1.0× 127 0.5× 24 1.5k

Countries citing papers authored by Paula W. Allan

Since Specialization
Citations

This map shows the geographic impact of Paula W. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula W. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula W. Allan more than expected).

Fields of papers citing papers by Paula W. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula W. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula W. Allan. The network helps show where Paula W. Allan may publish in the future.

Co-authorship network of co-authors of Paula W. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Paula W. Allan. A scholar is included among the top collaborators of Paula W. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula W. Allan. Paula W. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenthal, Eben L., Thomas K. Chung, William B. Parker, et al.. (2015). Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors. Annals of Oncology. 26(7). 1481–1487. 31 indexed citations
2.
Silva, Alcino J., William B. Parker, Paula W. Allan, Julio C. Ayala, & Jorge A. Benítez. (2015). Role of methylthioadenosine/S-adenosylhomocysteine nucleosidase in Vibrio cholerae cellular communication and biofilm development. Biochemical and Biophysical Research Communications. 461(1). 65–69. 9 indexed citations
3.
Hassan, Abdalla E. A., William B. Parker, Paula W. Allan, & John A. Secrist. (2009). Regioselective Metalation of 6-Methylpurines: Synthesis of Fluoromethyl Purines and Related Nucleosides for Suicide Gene Therapy of Cancer. Nucleosides Nucleotides & Nucleic Acids. 28(5-7). 642–656. 2 indexed citations
4.
Parker, William B., Esther W. Barrow, Paula W. Allan, et al.. (2004). Metabolism of 2-methyladenosine in Mycobacterium tuberculosis. Tuberculosis. 84(5). 327–336. 14 indexed citations
5.
Bennett, Eric M., Ruchi Anand, Paula W. Allan, et al.. (2003). Designer Gene Therapy Using an Escherichia coli Purine Nucleoside Phosphorylase/Prodrug System. Chemistry & Biology. 10(12). 1173–1181. 42 indexed citations
6.
Parker, William B., Paula W. Allan, Abdalla E. A. Hassan, et al.. (2002). Antitumor activity of 2-fluoro-2′-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase. Cancer Gene Therapy. 10(1). 23–29. 62 indexed citations
7.
Secrist, John A., William B. Parker, Paula W. Allan, et al.. (1999). Gene Therapy of Cancer: Activation of Nucleoside Prodrugs withE. coliPurine Nucleoside Phosphorylase. Nucleosides and Nucleotides. 18(4-5). 745–757. 35 indexed citations
8.
Hughes, Brian W., Scott A. King, Paula W. Allan, William B. Parker, & Eric J. Sorscher. (1998). Cell to Cell Contact Is Not Required for Bystander Cell Killing by Escherichia coli Purine Nucleoside Phosphorylase. Journal of Biological Chemistry. 273(4). 2322–2328. 56 indexed citations
9.
White, E. Lucile, Lucy M. Rose, Paula W. Allan, et al.. (1998). Polyamine Pools in HIV-Infected Cells. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(2). 101–103. 4 indexed citations
10.
Bennett, L. Lee, Paula W. Allan, Gussie Arnett, et al.. (1998). Metabolism in Human Cells of the d and l Enantiomers of the Carbocyclic Analog of 2′-Deoxyguanosine: Substrate Activity with Deoxycytidine Kinase, Mitochondrial Deoxyguanosine Kinase, and 5′-Nucleotidase. Antimicrobial Agents and Chemotherapy. 42(5). 1045–1051. 9 indexed citations
11.
Kulomaa, Markku S., Zsuzsa Bebők, William B. Parker, et al.. (1996). Development of drug targeting based on recombinant expression of the chicken avidin gene. Journal of drug targeting. 4(1). 41–49. 9 indexed citations
12.
Parker, William B., Paula W. Allan, Shri Niwas, Jane Montgomery, & L. Lee Bennett. (1994). Effect of 9-benzyl-9-deazaguanine, a potent inhibitor of purine nucleoside phosphorylase, on the cytotoxicity and metabolism of 6-thio-2'-deoxyguanosine.. PubMed. 54(7). 1742–5. 4 indexed citations
13.
Bennett, L. Lee, Lucy M. Rose, Paula W. Allan, et al.. (1979). Metabolism and metabolic effects of 8-aza-6-thioinosine and its rearrangement product, N-beta-D-ribofuranosyl-[1,2,3]thiadiazolo[5,4-d]-pyrimidin-7-amine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(3). 981–96. 4 indexed citations
14.
Bennett, Leonard L., et al.. (1976). Metabolic Studies with an α-Nucleoside, 9-α-D-Arabinofuranosyl-8-azaadenine. Molecular Pharmacology. 12(2). 242–250. 2 indexed citations
15.
Bennett, L. Lee, et al.. (1973). Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity.. PubMed. 33(3). 465–71. 16 indexed citations
16.
Bennett, L. Lee & Paula W. Allan. (1971). Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.. The Mouseion at the JAXlibrary (Jackson Laboratory). 31(2). 152–8. 41 indexed citations
17.
Allan, Paula W. & L. Lee Bennett. (1971). 6-Methylthioguanylic acid, a metabolite of 6-thioguanine. Biochemical Pharmacology. 20(4). 847–852. 27 indexed citations
18.
Hill, Donald L., et al.. (1971). Inhibition of Guanine Metabolism of Mammalian Tumor Cells by the Carbocyclic Analogue of Adenosine. Molecular Pharmacology. 7(4). 375–380. 21 indexed citations
19.
Allan, Paula W., et al.. (1969). The effects of urethan and N-methylformamide on pyrimidine metabolism.. PubMed. 29(1). 93–7. 2 indexed citations
20.
Bennett, L. Lee, et al.. (1966). Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine. Molecular Pharmacology. 2(5). 432–443. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernanda Canduri Breakdown of academic impact, for papers by Federico Focher Breakdown of academic impact, for papers by Gopalan Soman Breakdown of academic impact, for papers by Priscilla P. Saunders Breakdown of academic impact, for papers by I K Dev Breakdown of academic impact, for papers by Charles Garrett Breakdown of academic impact, for papers by David H. Ives Breakdown of academic impact, for papers by Shizuko Sei Breakdown of academic impact, for papers by D. B. Thomas Breakdown of academic impact, for papers by Gerald Bacher
Rankless by CCL
2026